We are live on ! Find out more
BPTH icon

Bio-Path Holdings

Delisted

BPTH was delisted on the 18th of February, 2025.

42 hedge funds and large institutions have $37.8M invested in Bio-Path Holdings in 2014 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,500% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 2

282% more funds holding

Funds holding: 11 → 42 (+31)

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

34% more capital inflows, than outflows

Capital inflows: $21.6M | Capital outflows: $16M

2.14% more ownership

Funds ownership: 12.98% → 15.12% (+2.1%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
42
Holders Change
+31
Holders Change %
+281.82%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
32
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BPTH Hedge Fund Activity: Q2 2014 in Review

42 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings (BPTH) for Q2 2014, worth a combined $37.8M — up 35% from $27.9M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new BPTH positions and 2 closed out — a net gain of 30 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $4.95M. The largest seller was Sabby Management, exiting entirely with an estimated $8.78M sold.

  • 42 institutional investors held Bio-Path Holdings (BPTH) as of Q2 2014, up from 11 in Q1 2014.
  • Funds reported $37.8M of Bio-Path Holdings stock for Q2 2014, up 35% quarter-over-quarter.
  • 32 funds opened new Bio-Path Holdings positions in Q2 2014 and 2 closed out, a net change of +30 holders.
  • The largest Bio-Path Holdings buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $4.95M added.
  • The largest Bio-Path Holdings seller in Q2 2014 was Sabby Management, an estimated $8.78M sold.

Based on aggregated 13F filings for Q2 2014.